These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33878855)

  • 1. A new combination of molecules for the treatment of androgenetic alopecia and telogen effluvium: a double-blind randomized, monocentric, placebo-controlled study.
    Rossi A; Magri F; DI Fraia M; Caro G; Fortuna MC; Piacentini M; Celleno L
    Ital J Dermatol Venerol; 2022 Feb; 157(1):78-83. PubMed ID: 33878855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.
    Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J
    EClinicalMedicine; 2021 Jul; 37():100978. PubMed ID: 34235415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita.
    Quercetani R; Rebora AE; Fedi MC; Carelli G; Mei S; Chelli A; Poli E
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):808-10. PubMed ID: 20946585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopecia.
    Cedirian S; Bruni F; Quadrelli F; Caro G; Fortuna M; Rossi A; Piraccini BM; Starace M
    J Cosmet Dermatol; 2023 Dec; 22(12):3347-3351. PubMed ID: 37415302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study.
    Turlier V; Darde MS; Loustau J; Mengeaud V
    J Eur Acad Dermatol Venereol; 2021 Nov; 35 Suppl 2():12-20. PubMed ID: 34668237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia.
    Gerkowicz A; Bartosińska J; Krakowski P; Karpiński R; Krasowska D; Raczkiewicz D; Kwasny M; Krasowska D
    Ann Agric Environ Med; 2024 Jun; 31(2):239-247. PubMed ID: 38940108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.
    Milani M; Colombo F;
    Skin Res Technol; 2023 Jun; 29(6):e13381. PubMed ID: 37357646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a new formulation kit (shampoo + lotion) containing anti-inflammatory and antioxidant agents to treat hair loss.
    Anzai A; Pereira AF; Malaquias KR; Guerra LO; Mercuri M
    Dermatol Ther; 2020 May; 33(3):e13293. PubMed ID: 32134172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finasteride increases anagen hair in men with androgenetic alopecia.
    Van Neste D; Fuh V; Sanchez-Pedreno P; Lopez-Bran E; Wolff H; Whiting D; Roberts J; Kopera D; Stene JJ; Calvieri S; Tosti A; Prens E; Guarrera M; Kanojia P; He W; Kaufman KD
    Br J Dermatol; 2000 Oct; 143(4):804-10. PubMed ID: 11069460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
    Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
    Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic treatment.
    Starace M; Carpanese MA; Alessandrini A; Bruni F; Piraccini BM
    Ital J Dermatol Venerol; 2023 Feb; 158(1):55-59. PubMed ID: 36645365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety.
    Russo PM; Fino E; Mancini C; Mazzetti M; Starace M; Piraccini BM
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):608-611. PubMed ID: 30394586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogen Hairs in Women with and without Hair Loss.
    Guarrera M; Rebora A
    Skin Appendage Disord; 2017 Oct; 3(4):193-196. PubMed ID: 29177147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
    Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
    Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial.
    El-Dawla RE; Abdelhaleem M; Abdelhamed A
    Indian J Dermatol Venereol Leprol; 2023; 89(2):195-203. PubMed ID: 35593290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women.
    Whiting DA; Waldstreicher J; Sanchez M; Kaufman KD
    J Investig Dermatol Symp Proc; 1999 Dec; 4(3):282-4. PubMed ID: 10674382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore
    Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R
    J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a new combination of a microemulsion and oral supplementation for androgenetic alopecia: an interventional multicentric study.
    D'Ovidio R; Magri F; Villa L; Leoncini PP; Caro G; Muscianese M; DI Fraia M; Chieco P; Hushcha Y; Rossi A
    Ital J Dermatol Venerol; 2022 Jun; 157(3):254-261. PubMed ID: 35068112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of telogen rate and increase of hair density in androgenetic alopecia by a cosmetic product: Results of a randomized, prospective, vehicle-controlled double-blind study in men.
    Welzel J; Wolff HH; Gehring W
    J Cosmet Dermatol; 2022 Mar; 21(3):1057-1064. PubMed ID: 33955628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.